# Viridian Therapeutics, Inc. (VRDN): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/vrdn for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Viridian Therapeutics, Inc. is a biotechnology firm committed to creating therapies for patients afflicted by serious illnesses. Its primary development efforts include VRDN-001, a humanized monoclonal anti-IGF-1R antibody currently advancing through Phase 1/2 clinical trials for thyroid eye disease (TED). The company's portfolio also features VRDN-002, an IGF-1R antibody undergoing Phase 1 clinical evaluation, alongside VRDN-003, a therapeutic antibody also designed to target IGF-1R for TED. Established in 2006, this Waltham, Massachusetts-based firm previously operated as Miragen Therapeu...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $22.37 USD |
| Market Cap | $2.53B |
| P/E (TTM) | — |
| EPS (TTM) | −$3.37 |
| 52-Week Range | $13.18 – $34.29 |
| Dividend Yield (TTM) | — |

## Dividend

VRDN has no dividend payment history in our records.

## Frequently Asked Questions

### What does Viridian Therapeutics, Inc. do?

Viridian Therapeutics, Inc. (VRDN) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is VRDN's market cap?

Viridian Therapeutics, Inc. (VRDN) has a market capitalization of approximately $2.53 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does VRDN pay a dividend?

No, Viridian Therapeutics, Inc. (VRDN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is VRDN profitable?

Viridian Therapeutics, Inc. (VRDN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has VRDN ever paid a dividend?

No. Dividend Data's records show no dividend payments from Viridian Therapeutics, Inc. (VRDN). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/vrdn
- Dividend history & safety: https://www.dividenddata.com/stocks/vrdn/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/vrdn/earnings
- Financial statements: https://www.dividenddata.com/stocks/vrdn/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/vrdn/valuation
- Peer comparison: https://www.dividenddata.com/stocks/vrdn/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.